Violation Tracker UK Parent Company Summary
Parent Company Name: Nordic Capital
Ownership Structure: privately held
Headquartered in: Sweden
Major Industry: private equity (including portfolio companies)
Specific Industry: private equity (including portfolio companies)
Penalty total since 2010: £94,502,933
Number of cases: 6
|Top Offence Groups (Groups Defined)||Penalty Total||Number of Cases
|Top Offence Types||Penalty Total||Number of Cases
|price-fixing or anti-competitive practices||£94,502,933||6|
: Parent-subsidiary linkages are based on current relationships and may vary from what was the case when a violation occurred.
Individual Penalty Cases:
Click on the company or penalty amount for more information on each case.
Download results as
(maximum 1000; for access to larger downloads contact Phil Mattera
|Company||Offence Type||Year||Agency||Penalty Amount .
|Advanz Pharma||price-fixing or anti-competitive practices||2021||UK-CMA||£43,000,000
|Advanz Pharma||price-fixing or anti-competitive practices||2021||UK-CMA||£40,900,000
|Focus Pharmaceuticals Limited and Mercury Pharma Group Ltd. and Concordia Investments (Jersey) Ltd. and Advanz Pharma Corp. Ltd. et al.||price-fixing or anti-competitive practices||2022||UK-CMA||£7,288,853
|Focus Pharmaceuticals Limited and Mercury Pharma Group Ltd. and Cinven Partners LLP et al.||price-fixing or anti-competitive practices||2022||UK-CMA||£1,843,380
|Focus Pharmaceuticals Ltd. and Focus Pharma Holdings Ltd. and Mercury Pharma Group Ltd.||price-fixing or anti-competitive practices||2022||UK-CMA||£921,357
|Focus Pharmaceuticals Limited and Focus Pharma Holdings Limited||price-fixing or anti-competitive practices||2022||UK-CMA||£549,343